You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《半日速報》恆指半日收報19,441點 升79點; 恆生科技指數半日收報4,096點 升18點 藥明生物跌逾18% 財險創新高
恆指半日收19,441點,升79點或0.4%。恆生科技指數報4,096點,升18點或0.5%。國指升46點或0.7%,報6,674點。 活躍重磅股表現: 阿裏巴巴(09988.HK) 收91.95元,上升2.4%; 平安(02318.HK) 收47.9元,上升0.8%; 友邦(01299.HK) 收74.15元,下跌0.8%; 美團(03690.HK) 收180.6元,上升0.4%; 騰訊(00700.HK) 收307.2元,上升0.1%; 異動恆指及國指成份股: 藥明生物(02269.HK) 收54.4元,下跌18.4%; 海底撈(06862.HK) 收17.96元,上升6.3%; 萬洲(00288.HK) 收5.48元,上升5.4%; 商湯-W(00020.HK) 收2.16元,下跌5.3%; 聯想集團(00992.HK) 收6.41元,上升5.1%; 申洲(02313.HK) 收76.65元,上升3.4%; 安踏體育(02020.HK) 收95.5元,上升3.2%; 銀娛(00027.HK) 收43.7元,上升3.2%; 比亞迪(01211.HK) 收228.6元,上升3.2%; 金沙(01928.HK) 收17.82元,上升3.1%; 異動綜合中小型股: 永泰生物-B(06978.HK) 收5元,上升42.9%; 樂普生物(02157.HK) 收15.58元,下跌37.9%; 再鼎醫藥-B(09688.HK) 收41.9元,上升15.1%; 藥明康德(02359.HK) 收70.75元,下跌14.4%; 泰格醫藥(03347.HK) 收65.65元,下跌14.2%; 康龍化成(03759.HK) 收43.2元,下跌12.6%; 瑞爾集團(06639.HK) 收7.55元,下跌10.1%; 美圖(01357.HK) 收0.99元,上升10%; 財險(02328.HK) 收8.84元,上升0.5%,創新高; ~
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account